News

Fighting Cancer Together: The Leukemia & Lymphoma Society Announces Kindred Healthcare as Official Presenting Sponsor for Light The Night

- Kindred Healthcare and Light The Night announce collaboration to create a world without blood cancers -

(Louisville, KY, July 22, 2019) The Kentucky & Southern Indiana Chapter of The Leukemia & Lymphoma Society (LLS), the world’s largest non-profit health organization dedicated to finding cures and ensuring access to treatments for all blood cancer patients has announced that Kindred Healthcare has joined LLS’s 2019 Light The Night®, as a Presenting Sponsor. Light The Night, an annual fundraising event, will take place on Thursday, October 10, 2019 at Slugger Field. Registration will begin at 5:30pm followed by opening ceremonies at 7pm.

Light The Night is a fundraising campaign benefiting LLS and their funding of research to find blood cancer cures. Coming together for a common goal, friends, family and co-workers form fundraising walk teams. Millions of consumers also help by donating at retail outlets. Culminating in inspiration and memorable evening walks every fall, participants in 140 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters and gold in memory of loved ones lost to cancer.
“We’re thrilled to have Kindred Healthcare as a Presenting Sponsor of this year’s Light The Night,” said, Erika Furlong, Executive Director at The Leukemia & Lymphoma Society. “We appreciate their generosity and are grateful for their commitment to help make this year’s Light The Night the best yet. We are taking steps to end cancer.”

LLS was founded by a family for families, beginning 70 years ago at a time when a diagnosis of leukemia was nearly 100% fatal. Now, with the development of new treatments for childhood leukemia, to today’s advances in precision medicine and immunotherapy, LLS has had a colossal impact on advancing cancer cures, and changing the way cancer is treated and the care for patients.

Through its efforts it has invested nearly $1.3 billion in cutting-edge research to advance therapies. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Yet, despite these advances, about one third of patients with blood cancer still do not survive even five years after their diagnosis.

To form a team or to learn more, please call the Deanna Keal (at 502-719-0546) or visit www.lightthenight.org/events/Louisville.


About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

For additional information visit lls.org/lls-newsnetwork. Follow us on Facebook, Twitter, and Instagram.